Sensera has acquired Nanotron Technologies
Sensera Ltd. has acquired Nanotron Technologies GmbH.
Sensera is an Internet of Things (IoT) sensor solution provider. The company designs and manufactures specialized high-performance sensors and modules in the rapidly growing global wireless sensor networks industry.
Headquartered in Germany, Nanotron Technologies is a leading provider of location awareness services. The Nanotron platform delivers a complete integrated sensor system consisting of chips, modules and software that enable precise real-time positioning and concurrent wireless communication.
Oaklins’ team in Australia acted as buy-side advisor in this transaction.



Matt Morgan
Executive Chairman, Sensera Ltd.
Talk to the deal team
Related deals
BodhiCedric has acquired Network Media from Jellysmack
The media holding company BodhiCedric has acquired Network Media, an innovator in the creator economy, from Jellysmack, the global creator company.
Learn moreCustomerXPs Software (Clari5) has been acquired by Perfios Software Solutions
Bengaluru-based SaaS firm Perfios Software Solutions Private Ltd. has acquired 100% of the equity shares in the fraud-detection platform CustomerXPs Software Private Ltd. (Clari5) for an undisclosed amount, enhancing its anti-financial crime management suite for financial institutions.
Learn moreBayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Learn more